Vascular Rejuvenation using EDTA
Dr Gervasio Lamas and Dr Isabelle Schiffer speaking in online meetup about how EDTA therapy affects vascular diseases, organized by Forever Healthy Foundation (FREE)
We are happy that Gervasio A Lamas, M.D. will join us as a guest speaker. Dr. Lamas is chair of medicine and chief of cardiology at Mount Sinai Medical Center and was the lead investigator of the TACT trial (Trial to Assess Chelation Therapy). He initiated this multi-center double-blinded clinical trial, which took 10 years to be completed, to evaluate the efficacy and safety of EDTA chelation for the treatment of coronary and peripheral artery disease. The results of the trial surprised the medical world, including Lamas, and led to further large-scale trials on chelation therapy (TACT2, TACT3a).
Dr. Isabelle Schiffer will give an overview of the research that Forever Healthy conducted to evaluate the use of EDTA chelation therapy for vascular rejuvenation. The foundation identified over 2000 publications and included 111 relevant studies to assess the risks and the benefits of chelation therapy.
Summary of event available at: https://liveforever.club/article/summary-of-dr-gervasio-lamas-presentation-on-edta-clinical-trial
Visit website: https://www.meetup.com/forever-healthy/events/275861226/
Forever Healthy Foundation
- A private, non-profit initiative with the mission to enable people to vastly extend their healthy lifespan
Interested in more events? View the club's event calendar.
Mentioned in this Resource
Chair of Medicine and Chief of Cardiology at Mount Sinai Medical Center Miami Beach.
Scientific Communication at Forever Healthy Foundation and researcher at Max Planck Institute for Biology of Ageing
Vascular Rejuvenation using EDTA News
Summary of Dr Gervasio Lamas presentation on EDTA clinical trial
Live Forever Club - 05-Feb-2021
5-year mortality for diabetic heart attach patients reduced by 43%